Cost-utility analysis of a 12-week whole-body vibration based treatment for people with type 2 diabetes: reanalysis of a RCT in a primary care context

被引:6
作者
Alfonso-Rosa, R. M. [1 ]
del Pozo-Cruz, J. [1 ]
del Pozo-Cruz, B. [2 ]
Sanudo, B. [1 ]
Abellan-Perpinan, J. M. [3 ]
机构
[1] Univ Seville, Fac Educ, Dept Phys Educ & Sport, Seville 41013, Spain
[2] Univ Auckland, Dept Sport & Exercise Sci, Auckland 1072, New Zealand
[3] Univ Murcia, Dept Appl Econ, Fac Econ & Business, E-30100 Murcia, Spain
关键词
HEALTH; LIFE;
D O I
10.1016/j.puhe.2015.02.025
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:993 / 995
页数:3
相关论文
共 12 条
[1]   LOWERING THE FLOOR' OF THE SF-6D SCORING ALGORITHM USING A LOTTERY EQUIVALENT METHOD [J].
Abellan Perpinan, Jose Maria ;
Sanchez Martinez, Fernando Ignacio ;
Martinez Perez, Jorge Eduardo ;
Mendez, Ildefonso .
HEALTH ECONOMICS, 2012, 21 (11) :1271-1285
[2]  
Abellan-Perpinan JM, 2011, ESTIMACION CON UNPUB
[3]   The estimation of a preference-based measure of health from the SF-36 [J].
Brazier, J ;
Roberts, J ;
Deverill, M .
JOURNAL OF HEALTH ECONOMICS, 2002, 21 (02) :271-292
[4]   COST-EFFECTIVENESS OF EXERCISE PROGRAMS IN TYPE 2 DIABETES [J].
Coyle, Doug ;
Coyle, Kathryn ;
Kenny, Glen P. ;
Boule, Normand G. ;
Wells, George A. ;
Fortier, Michelle ;
Reid, Robert D. ;
Phillips, Penny ;
Sigal, Ronald J. .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (03) :228-234
[5]   Effects of a 12-wk whole-body vibration based intervention to improve type 2 diabetes [J].
del Pozo-Cruz, Borja ;
Alfonso-Rosa, Rosa M. ;
del Pozo-Cruz, Jesus ;
Sanudo, Borja ;
Rogers, Michael E. .
MATURITAS, 2014, 77 (01) :52-58
[6]   Quality of Life and Cost-effectiveness of a 3-Year Trial of Lifestyle Intervention in Primary Health Care [J].
Eriksson, Margareta K. ;
Hagberg, Lars ;
Lindholm, Lars ;
Malmgren-Olsson, Eva-Britt ;
Osterlind, Jonas ;
Eliasson, Mats .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (16) :1470-1479
[7]   The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance [J].
Herman, WH ;
Hoerger, TJ ;
Brandle, M ;
Hicks, K ;
Sorensen, S ;
Zhang, P ;
Hamman, RF ;
Ackermann, RT ;
Engelgau, MM ;
Ratner, RE .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) :323-332
[8]  
Pinto JL, 2001, VALOR MONETARIO SALU
[9]  
Pinto JL, 2005, EKONOMIAZ, V13
[10]   Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report [J].
Ramsey, S ;
Willke, R ;
Briggs, A ;
Brown, R ;
Buxton, M ;
Chawla, A ;
Cook, J ;
Glick, H ;
Liljas, B ;
Petitti, D ;
Reed, S .
VALUE IN HEALTH, 2005, 8 (05) :521-533